Letter to the Senate HELP Committee Opposing Draft Legislation Proposing Incentives for Antibiotic Development
Public Citizen comments on the March 29 discussion draft of legislation amending the Federal Food, Drug, and Cosmetic Act to incentivize new antibiotic development that was prepared by the Senate Committee on Health, Education, Labor, and Pensions that would provide drug companies with large financial incentives to develop new antibiotics and mandate that the Food and Drug Administration (FDA) review these drugs more rapidly.